Innoviva (INVA) Cash from Investing Activities (QoQ) (2010 - 2025)
Innoviva (INVA) Cash from Investing Activities (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Innoviva | 1.58 Bn | 979.49 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -49.10% |
| Jun 30, 2025 | 195.52% |
| Sep 30, 2022 | -1,801.51% |
| Jun 30, 2022 | 98.24% |
| Sep 30, 2021 | -29.32% |
| Jun 30, 2021 | 441.07% |
| Mar 31, 2021 | 91.63% |
| Dec 31, 2020 | -3,611.54% |
| Sep 30, 2020 | -21.43% |
| Jun 30, 2020 | -143.63% |
| Mar 31, 2020 | -69.14% |
| Dec 31, 2019 | 426.25% |
| Sep 30, 2019 | -179.26% |
| Jun 30, 2019 | 127.11% |
| Mar 31, 2019 | -62.67% |
| Dec 31, 2018 | -437.18% |
| Sep 30, 2018 | 48.95% |
| Jun 30, 2018 | -65.76% |
| Mar 31, 2018 | 202.45% |
| Dec 31, 2017 | -18.86% |